Atorvastatin for Reduction of Myocardial Damage During Angioplasty-Acute Coronary Syndromes - ARMYDA-ACS – Presented at ACC 2007

Description:

The goal of the trial was to evaluate the effect of atorvastatin compared with placebo among patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI).